• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Retrophin Completes Acquisition of Orphan Technologies americanpharmaceuticalreview
    November 25, 2020
    Retrophin announced the completion of its previously announced acquisition of Orphan Technologies Limited, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58 for the treatment of classical ...
  • Retrophin to Acquire Orphan Technologies americanpharmaceuticalreview
    October 26, 2020
    Retrophin has entered into a definitive agreement to acquire Orphan Technologies, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58 for the treatment of classical homocystinuria (HCU).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service